Two molecular control factors play a decisive role in what is known as splicing, the cutting and assembly of mature messenger ...

They succeeded once they were able to isolate the splicing complexes of the fungus that were in the midst of quality control ...

Molecure achieved key milestones in the development of its innovative therapies in 2024 and plans to accelerate research and ...

Cell-free systems, which can express an easily detectable protein with a DNA or mRNA template without constraints of living ...

Avidity Biosciences, Inc.'s innovative AOC platform and promising clinical programs make it a high-risk, high-reward ...

In this article, we are going to look at where Moderna, Inc. (NASDAQ:MRNA) stands against other biotech stocks. Biotech Sector Set for Growth Amid Innovation and Investor Interest The ...

A new study has found that messenger RNA can travel between different stem cells and reprogram human cells to an earlier ...

The FDA cleared the investigational new drug (IND) application for EVM14. EVM14 is an off-the-shelf tumor-associated antigen ...

as the company’s technology performs multiple functions. This includes protecting mRNA treatment from degradation following administration into the body, delivering the mRNA to the appropriate ...

CureVac and partner GSK are, meanwhile, also developing an mRNA-based flu vaccine, but are a little further back in development, as their shot is in phase 1 testing.

EVM14 received U.S. FDA clearance for its IND application, becoming Everest's first internally discovered program, and the first mRNA therapeutic cancer vaccine to be cleared ...